Mounjaro vs Wegovy: Which Is Better for Weight Loss in the UK?
A detailed comparison of how these medications work, what the differences mean in real life, and how to choose the right option for you
Prescription weight loss injections such as Mounjaro and Wegovy are increasingly discussed in the UK as treatment options for people who have struggled to achieve or maintain weight loss through lifestyle changes alone.
With both medications available privately, many people reach the same question: “Which one is better for weight loss?”
The honest answer is that “better” depends on the individual. This guide provides a clear, evidence-based comparison and helps you think through which option may be the best fit — without hype or pressure.
Medical Reviewer: Shadeia Younis, Pharmacist Prescriber (UK-registered) | Last reviewed: February 2026
For an overview of all available options, see our Weight Loss Injections in the UK: Complete Guide (Clinician-Led, 2026).
What’s on this page
How Mounjaro and Wegovy Work
Both medications support weight loss by influencing appetite regulation and digestion, but they do so in slightly different ways.
Wegovy (Semaglutide)
Wegovy contains semaglutide, a GLP-1 receptor agonist. GLP-1 is a naturally occurring hormone involved in signalling fullness to the brain, slowing stomach emptying, and reducing hunger between meals.
Many people describe Wegovy as making food feel less dominant, helping them feel satisfied with smaller portions.
Mounjaro (Tirzepatide)
Mounjaro contains tirzepatide, which acts on two hormone receptors: GLP-1 (similar to Wegovy) and GIP, a hormone involved in energy balance and insulin response.
This dual-action mechanism may amplify appetite suppression and influence how the body processes energy, which is why Mounjaro has shown higher average weight-loss results in some studies.
Shared principles
Despite their differences, both medications are taken once weekly by injection, require gradual dose escalation, are prescribed alongside lifestyle support, and aim to support long-term, sustainable change. Neither is a quick fix or replacement for healthy habits.
How They Compare in Clinical Studies
Clinical trials show that both can support meaningful weight loss, but average results differ.
| Medication | Average Weight Loss | Timeframe |
|---|---|---|
| Mounjaro (tirzepatide) | ~20–22% of starting weight | Longer-term treatment |
| Wegovy (semaglutide) | ~12–17% of starting weight | Comparable period |
These are averages, not predictions. Individual results depend on starting weight, dose tolerance, nutrition and activity, duration, and individual biological response. Higher averages do not automatically mean a medication is “better” for every person.
Differences in Dosing and Treatment Journey
Both use gradual dose escalation, but their schedules and endpoints differ.
Wegovy Dosing
- Starts at 0.25mg weekly
- Gradually increases to 2.4mg weekly
- Early doses focus on tolerance
See: Wegovy Dosages Explained: 0.25mg to 2.4mg
Mounjaro Dosing
- Starts at 2.5mg weekly
- Can increase up to 15mg weekly
- Dose progression may continue over a longer period
See: Mounjaro Dosage Schedule Explained
What this means practically
Wegovy often feels more predictable early on. Mounjaro may offer greater appetite suppression at higher doses. Some people tolerate one better than the other. Dose speed and comfort matter just as much as outcomes.
What the Differences Feel Like in Everyday Life
Wegovy: Common Experiences
- Gradual appetite reduction
- Feeling full sooner
- Smaller, steadier changes over time
- Often described as “subtle but consistent”
Mounjaro: Common Experiences
- Stronger appetite suppression for some
- More noticeable changes at higher doses
- Potentially greater weight loss over longer periods
- May require more careful dose pacing
Neither experience is universal — and neither is inherently better.
Side Effects and Tolerability
Both medications share similar side-effect profiles, particularly involving digestion. Commonly reported effects include nausea, early fullness, changes in bowel habits, and temporary fatigue.
Side effects are most common at the start of treatment and during dose increases. Many people find these effects settle with time, especially with appropriate guidance.
Practical guidance:
Cost and Access Considerations
Cost can be a deciding factor for many people. Both are privately prescribed for most patients, monthly costs vary by dose and provider, and higher doses generally cost more.
Detailed pricing guides:
- Wegovy Cost UK 2026: Private Prescription Prices Explained
- Mounjaro Cost UK: Private Prescription Prices Explained
NHS access exists but remains limited and highly criteria-dependent.
Switching Between Treatments
Some people begin on one medication and later consider switching. This may be discussed if side effects limit dose progression, weight-loss response plateaus, or circumstances change.
Switching should always be clinician-guided to ensure safe timing and dosing. See our guide on switching from Wegovy to Mounjaro safely.
Why Professional Guidance Matters
Choosing between Mounjaro and Wegovy isn’t about chasing the highest percentage — it’s about selecting a treatment that fits your health profile and can be maintained.
A prescriber considers medical history and conditions, current medications, tolerance and side-effect risk, lifestyle and support needs, and long-term sustainability.
For a broader look at other treatment comparisons, see our guide on Wegovy vs Saxenda.
Clinician-Led Care at Slinic
At Slinic Pharmacy, treatment choice is guided by clinical suitability rather than trends. All prescriptions are:
- Reviewed by UK-registered prescribers
- Dispensed by a GPhC-regulated pharmacy
- Supported by structured follow-up
Clinical oversight is led by Shadeia Younis, ensuring decisions remain patient-centred, cautious, and transparent.
Frequently Asked Questions
Neither is universally better. Suitability depends on individual response, tolerance, health profile, and goals.
Not necessarily. While clinical trial averages are higher, individual outcomes vary significantly.
Both medications are prescribed under UK safety standards when clinically appropriate.
Yes, in some cases, but only with medical guidance to ensure safe timing and dosing.
They are similar, though individuals may tolerate one better. Common effects include nausea, early fullness, and digestive changes.
A clinical consultation is the best way to assess suitability based on your medical history, tolerance, lifestyle, and goals.
Choosing With Confidence
Mounjaro and Wegovy are both effective tools when used appropriately. The right choice isn’t about which is “stronger” — it’s about which fits your body, your health, and your life.
With Slinic Pharmacy, you’ll receive
- Personalised guidance on which option may suit you
- Clear explanations of how each treatment works
- Ongoing clinical support throughout treatment
Slinic — Your trusted partner for weight loss success
GPhC Registered Pharmacy: 1033729 | Superintendent Pharmacist: Shadeia Younis (GPhC: 2052119)
Award-winning clinical excellence | Transparent pricing | Guaranteed stock